Amiri, N., Forouzesh, F., Nazemalhosseini- Mojarad, E., Shabani, M. 2020. The effect of sodium butyrate as a histone deacetylase inhibitor on the gene expression of Bid in HT-29 human colorectal cancer cell line. Medical Science Journal of Islamic Azad University, Tehran Medical Branch, 30(1): 40-50.
Arvelo, F., Sojo, F. & Cotte, C. 2015. Biology of colorectal cancer. Ecancermedicalscience: 9.
Chirakkal, H., Leech, S., Brooks, K., Prais, A., Waby, J. & Corfe, B. 2006. Upregulation of BAK by butyrate in the colon is associated with increased Sp3 binding. Oncogene, 25: 7192-7200.
Chopin, V., Toillon, R. A., Jouy, N. & Bourhis, X. L. 2002. Sodium butyrate induces P53‐independent, Fas‐mediated apoptosis in MCF‐7 human breast cancer cells. British journal of pharmacology, 135: 79-86.
Chueh, A. C., Tse, J. W., Togel, L. & Mariadason, J. M. 2015. Mechanisms of histone deacetylase inhibitor-regulated gene expression in cancer cells. Antioxidants & redox signaling, 23: 66-84.
Davie, J. R. 2003. Inhibition of histone deacetylase activity by butyrate. The Journal of nutrition, 133: 2485S-2493S.
Dejakam, A., Dejakam, A. and Hekmat, A. 2020. Evaluating of bdnf expression in blood cells of opium recovering patients with a new treatment method: A molecular marker. Research in Karyotic Cell &Tissue, 1(1): 16-25.
Del Poeta, G. Venditti, A. Del Principe, M.I., et al. 2003. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood, 101:2125–2131.
Esteller, M. 2008. Epigenetics in cancer. New England Journal of Medicine, 358: 1148-1159.
Farkas, R. Pozsgai, E., Bellyei, S.Z., Cseke, L., Szigeti, A., Vereczkei, A., Marton, S., Mange, L., Horvath, O.P., Papp, A. 2011. Correlation between tumorassociated proteins and response to neoadjuvant treatment in patients with advanced squamous-cell esophageal cancer. Anticancer research. 31(5):1769-75.
Forouzesh, F., Talebi , S., Shahbazi, N. 2018. Anticancer effects of sodium butyrate on human colon cancer Caco2 cell line. Journal of Fasa University of Medical Sciences, 8: 735-745.
Forouzesh, F., Ghiaghi, M., & Rahimi, H. 2020. Effect of sodium butyrate on HDAC8 mRNA expression in colorectal cancer cell lines and molecular docking study of LHX1 - sodium butyrate interaction. EXCLI Journal, 19: 1038-1051.
Fraga,M. F., Ballestar, E., Villar-Garea, A., Boix-Chornet, M., Espada, J., Schotta, G., Bonaldi, T., Onaldi, T., Haydon, C., Ropero, S. & Petrie, K. 2005. Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer. Nature genetics, 37: 391-400.
Gum, J., Kam W., Byrd, J., Hicks, J., Sleisenger, M. & Kim, Y. 1987. Effects of sodium butyrate on human colonic adenocarcinoma cells. Induction of placental-like alkaline phosphatase. Journal of Biological Chemistry, 262: 1092-1097.
Hekmat, A. and Saboury, A.A. 2019. Structural effects of the syntheticcobalt–manganese-zinc ferrite nanoparticles (Co0.3Mn0.2Zn0.5 Fe2O4NPs) on DNA and its antiproliferative effect on t47dcells. BioNanoScience, 9(4): 821-832.
Huerta, S., Goulet, E. J. & Livingston, E. H. 2006. Colon cancer and apoptosis. The American Journal of Surgery, 191: 517-526.
Jia, Y. & Guo, M. 2013. Epigenetic changes in colorectal cancer. Chinese journal of cancer, 32: 21.
Khan, S. & Jena, G. 2014. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat. Chemico-biological interactions, 213: 1-12.
Khaw, S.L., Mérino, D., Anderson, M.A., Glaser, S.P., Bouillet, P., Roberts, A.W. & Huang, D.C.S.
2014. Both leukaemic and normal peripheral B lymphoid cells are highly sensitive to the selective Pharmacological inhibition of prosurvival Bcl-2 with ABT-199. Leukemia,28:1207–1215.
Kilm, Y. S., Tsao, D., Siddiqui , B., Whitehead, J. S., Arnstein , P., Bennett , J. & Hicks, J. 1980. Effects of sodium butyrate and dimethylsulfoxide on biochemical properties of human colon cancer cells. Cancer, 45: 1185-1192.
Koff, J. L., Ramachandiran, S. & Bernal-Mizrachi, L. 2015. A time to kill: targeting apoptosis in cancer. International journal of molecular sciences, 16: 2942-2955.
Kulsoom, B., Shamsi, T.S., Afsar, N.A., Memon, Z., Ahmed, N., Hasnain, S.N. 2018. Bax, Bcl-2, and Bax/Bcl-2 as prognostic markers in acute myeloid leukemia: are we ready for Bcl-2-directed therapy? Cancer Management and Research,10: 403-416.
Mariadason, J. M. 2008. HDACs and HDAC inhibitors in colon cancer. Epigenetics, 3: 28-37.
Qian, H.-R., Shi, Z.Q., Zhu, H.P., Gu, L.H., Wang, X.F. & Yang, Y. 2017. Interplay between apoptosis and autophagy in colorectal cancer. Oncotarget, 8: 62759.
Mashayekhi, A., Forouzesh, F., and Mashayekhi, M. 2021. Promotion of Extrinsic Apoptosis Pathway in HCT‐116 Human Colorectal Cancer Cell Line by Sodium Butyrate as Histone Deacetylase Inhibitor. Iran Red Crescent Medical Journal. 23(1):e190.
Ruemmele, F., Schwartz, S., Seidman, E., Dionne, S., Levy, E. & Lentze, M. 2003. Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway. Gut, 52: 94-100.
Salimi, V., Shahsavari, Z., Safizadeh, B., Hosseini, A., Khademian, N., and Tavakoli-Yaraki, M. 2017. Sodium butyrate promotes apoptosis in breast cancer cells through reactive oxygen species (ROS) formation and mitochondrial impairment. Lipids Health Dis, 16: 208.
Shadmani, F. K., Ayubi, E., Khazaei, S., Sani, M., Hanis, S. M., Khazaei, S., Soheylizad, M., & Mansori, K. 2017. Geographic distribution of the incidence of colorectal cancer in Iran: a population-based study. Epidemiology and health, 39: e2017020.
Sharma, S., Kelly, T. K., & Jones, P. A. 2010. Epigenetics in cancer. Carcinogenesis, 31: 27-36.
Spurling, C. C., Godman, C. A., Noonan, E. J., Rasmussen, T. P., Rosenberg, D. W.,. & Giardina, C. 2008. HDAC3 overexpression and colon cancer cell proliferation and differentiation. Molecular Carcinogenesis: Published in cooperation with the University of Texas MD Anderson Cancer Center, 47: 137-147.
Stunkel, W., Peh, B. K., Tan, Y. C., Nayagam, V. M., Wang, X., Salto-Tellez, M., Ni, B., Entzeroth, M., & Wood, J. 2007. Function of the SIRT1 protein deacetylase in cancer. Biotechnology Journal: Healthcare Nutrition Technology, 2: 1360-1368.
Wang, W., Fang, D., Zhang, H., Xue, J., Wangchuk, D., Du, J., Jiang, L. 2020. Sodium Butyrate Selectively Kills Cancer Cells and Inhibits Migration in Colorectal Cancer by Targeting Thioredoxin-1. OncoTargets and Therapy 13: 4691-4704.
Watson, A. 2004. Apoptosis and colorectal cancer. Gut, 53: 1701-1709.
West, A. C. & Johnstone, R. W. 2014. New and emerging HDAC inhibitors for cancer treatment. The Journal of clinical investigation, 124:30-39.
Wilson, A. J., Byun, D.S., Popova, N., Murray, L. B., Litalien, K., Sowa, Y., Aramgo, D., Velcich, A., Augenlicht, L. H., & Mariadason, J. M. 2006. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. Journal of Biological Chemistry, 281: 13548-13558.
Xu, F., Zhang, K., & Grunstein, M. 2005. Acetylation in histone H3 globular domain regulates gene expression in yeast. Cell, 121: 375-385.
Yan, W., & Guo, M. 2015. Epigenetics of colorectal cancer. Methods in Molecular Biology, 1238:405-24
Zhu, P., Martin, E., Mengwasser, J., Schlag, P., Janssen, K.P. & Gottlicher, M. 2004. Induction of HDAC2 expression upon loss of APC in colorectal tumorigenesis. Cancer cell, 5: 455-463.